• FirefoxInstall the new Firefox »
  •  Dow Up 0.26% Nasdaq Up 0.44%

    ImmunoGen, Inc. (IMGN)

    -NasdaqGS
    7.94 Up 0.21(2.72%) 10:09AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:7.73
    Open:7.77
    Bid:7.90 x 1000
    Ask:7.91 x 500
    1y Target Est:8.02
    Beta:1.27
    Earnings Date:Apr 23 - Apr 27 (Est.)
    Day's Range:7.73 - 7.97
    52wk Range:5.34 - 17.08
    Volume:125,690
    Avg Vol (3m):1,863,590
    Market Cap:683.69M
    P/E (ttm):N/A
    EPS (ttm):-0.85
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IMGNUp 2.72%683.69M
    PFEUp 0.32%212.98B
    RHHBYDown 0.24%N/A
    SGENUp 3.67%4.53B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.98
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.65
    Quarterly EPS Est (Mar-15) :-0.25
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback